Explore the words cloud of the REDOXIT project. It provides you a very rough idea of what is the project "REDOXIT" about.
The following table provides information about the project.
Coordinator |
UNIVERSITY OF SURREY
Organization address contact info |
Coordinator Country | United Kingdom [UK] |
Project website | https://www.surrey.ac.uk/redoxit |
Total cost | 144˙000 € |
EC max contribution | 144˙000 € (100%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2014 |
Funding Scheme | MSCA-RISE |
Starting year | 2015 |
Duration (year-month-day) | from 2015-07-01 to 2019-06-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITY OF SURREY | UK (GUILDFORD) | coordinator | 40˙500.00 |
2 | UNIVERSITATSKLINIKUM ERLANGEN | DE (ERLANGEN) | participant | 58˙500.00 |
3 | ASTON UNIVERSITY | UK (BIRMINGHAM) | participant | 31˙500.00 |
4 | REDOXIS AB | SE (LUND) | participant | 13˙500.00 |
We are proposing a four-year programme of knowledge transfer and networking between University of Surrey (SURREY, UK), Aston University (ASTON, UK), Friedrich-Alexander Universitat (UKER, Germany) and Redoxis AB (Redoxis, Sweden). The project targets an emerging area of biology, i.e. reactive oxygen species (ROS)-mediated regulation of immunology and ageing; it brings together the application of small molecule candidate drugs to generate ROS and uses innovative approaches to biomarker identification in models of chronic immune disease. This research has significant potential for application in human health and is of particular relevance to the ageing population. Training, knowledge transfer and skills exchange in this emergent area is important to extend the EU’s reach through cutting edge expertise. Interchange in this way will facilitate and promote early career researcher development into tomorrow’s research leaders. It will encourage new, cross-European collaboration between academia and industry. This tri-partite consortium brings together groups with very complementary expertise for knowledge exchange to benefit early career researchers: ASTON – in the biochemical analyses of ROS; SURREY in thiol oxidation and effects in vitro and ex vivo on and within immune cells relevant for biomarker development in chronic disease; UKER - in animal models of chronic diseases such as systemic lupus erythematosus (SLE) and arthritis; and Redoxis on development of novel drugs that stimulate production of ROS from the NOX2 enzyme as means to modulate chronic inflammation. The project objectives and challenges present a balanced mix between industrial application and basic science, with a focus on knowledge transfer and drug development. Through future collaborative funding, we anticipate far-reaching applications of redox modulators to manage chronic disease and increase the knowledge of both autoimmunity and ageing of the immune system.
Winter School on cell analysis | Other | 2019-11-29 10:50:34 |
Summer School on advances in free radical research | Other | 2019-11-29 10:50:34 |
Open workshop on inter-sectoral drug development | Other | 2019-11-29 10:50:34 |
Take a look to the deliverables list in detail: detailed list of REDOXIT deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Markus H. Hoffmann, Helen R. Griffiths The dual role of ROS in autoimmune and inflammatory diseases: Evidence from preclinical models published pages: , ISSN: 0891-5849, DOI: 10.1016/j.freeradbiomed.2018.03.016 |
Free Radical Biology and Medicine | 2019-11-29 |
2018 |
Viktor Reshetnikov, Jonas Hahn, Christian Maueröder, Christine Czegley, Luis Enrique Munoz, Martin Herrmann, Markus H. Hoffmann, Andriy Mokhir Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.01827 |
Frontiers in Immunology 9 | 2019-11-29 |
2017 |
Deborah Kienhöfer, Jonas Hahn, Julia Stoof, Janka Zsófia Csepregi, Christiane Reinwald, Vilma Urbonaviciute, Caroline Johnsson, Christian Maueröder, Malgorzata J. Podolska, Mona H. Biermann, Moritz Leppkes, Thomas Harrer, Malin Hultqvist, Peter Olofsson, Luis E. Munoz, Attila Mocsai, Martin Herrmann, Georg Schett, Rikard Holmdahl, Markus H. Hoffmann Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps published pages: e92920, ISSN: 2379-3708, DOI: 10.1172/jci.insight.92920 |
JCI Insight 2/10 | 2019-11-29 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REDOXIT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "REDOXIT" are provided by the European Opendata Portal: CORDIS opendata.